🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
174.35
-1.06 (-0.60%)
At close: Nov 20, 2026, 4:00 PM EST
173.83
-0.52 (-0.30%)
After-hours: Nov 20, 2026, 7:58 PM EST

AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of $272.50 billion. The enterprise value is $298.39 billion.

Market Cap272.50B
Enterprise Value 298.39B

Important Dates

The last earnings date was Friday, October 30, 2026, before market open.

Earnings Date Oct 30, 2026
Ex-Dividend Date Aug 7, 2026

Share Statistics

AstraZeneca has 1.55 billion shares outstanding. The number of shares has decreased by -0.02% in one year.

Current Share Class 1.55B
Shares Outstanding 1.55B
Shares Change (YoY) -0.02%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.04%
Owned by Institutions (%) 65.91%
Float 1.54B

Valuation Ratios

The trailing PE ratio is 25.07 and the forward PE ratio is 15.76.

PE Ratio 25.07
Forward PE 15.76
PS Ratio 4.37
Forward PS 4.12
PB Ratio 5.27
P/TBV Ratio n/a
P/FCF Ratio 26.69
P/OCF Ratio 20.59
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.02, with an EV/FCF ratio of 29.23.

EV / Earnings 27.05
EV / Sales 4.78
EV / EBITDA 14.02
EV / EBIT 18.54
EV / FCF 29.23

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.66.

Current Ratio 1.01
Quick Ratio 0.79
Debt / Equity 0.66
Debt / EBITDA 1.58
Debt / FCF 3.36
Interest Coverage 11.05

Financial Efficiency

Return on equity (ROE) is 22.57% and return on invested capital (ROIC) is 18.00%.

Return on Equity (ROE) 22.57%
Return on Assets (ROA) 9.41%
Return on Invested Capital (ROIC) 18.00%
Return on Capital Employed (ROCE) 18.16%
Weighted Average Cost of Capital (WACC) 4.93%
Revenue Per Employee $655,983
Profits Per Employee $115,983
Employee Count95,100
Asset Turnover 0.53
Inventory Turnover 1.69

Taxes

In the past 12 months, AstraZeneca has paid $2.27 billion in taxes.

Income Tax 2.27B
Effective Tax Rate 17.04%

Stock Price Statistics

The stock price has decreased by -3.04% in the last 52 weeks. The beta is 0.16, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y) 0.16
52-Week Price Change -3.04%
50-Day Moving Average 170.71
200-Day Moving Average 179.99
Relative Strength Index (RSI) 44.21
Average Volume (20 Days) 2,830,629

Short Selling Information

The latest short interest is 3.03 million, so 0.20% of the outstanding shares have been sold short.

Short Interest 3.03M
Short Previous Month 2.62M
Short % of Shares Out 0.20%
Short % of Float 0.20%
Short Ratio (days to cover) 0.99

Income Statement

In the last 12 months, AstraZeneca had revenue of $62.38 billion and earned $11.03 billion in profits. Earnings per share was $6.96.

Revenue62.38B
Gross Profit 51.02B
Operating Income 16.10B
Pretax Income 13.30B
Net Income 11.03B
EBITDA 21.28B
EBIT 16.10B
Earnings Per Share (EPS) $6.96
Full Income Statement

Balance Sheet

The company has $8.17 billion in cash and $34.33 billion in debt, with a net cash position of -$26.16 billion or -$16.87 per share.

Cash & Cash Equivalents 8.17B
Total Debt 34.33B
Net Cash -26.16B
Net Cash Per Share -$16.87
Equity (Book Value) 51.81B
Book Value Per Share 33.35
Working Capital 181.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $13.23 billion and capital expenditures -$3.02 billion, giving a free cash flow of $10.21 billion.

Operating Cash Flow 13.23B
Capital Expenditures -3.02B
Depreciation & Amortization 5.18B
Net Borrowing 564.00M
Free Cash Flow 10.21B
FCF Per Share $6.58
Full Cash Flow Statement

Margins

Gross margin is 81.78%, with operating and profit margins of 25.80% and 17.68%.

Gross Margin 81.78%
Operating Margin 25.80%
Pretax Margin 21.32%
Profit Margin 17.68%
EBITDA Margin 34.11%
EBIT Margin 25.80%
FCF Margin 16.37%

Dividends & Yields

This stock pays an annual dividend of $3.23, which amounts to a dividend yield of 1.85%.

Dividend Per Share $3.23
Dividend Yield 1.85%
Dividend Growth (YoY) 3.19%
Years of Dividend Growth 1
Payout Ratio 46.19%
FCF Payout Ratio 49.07%
Buyback Yield 0.02%
Shareholder Yield 1.87%
Earnings Yield 3.99%
FCF Yield 3.75%
Dividend Details

Analyst Forecast

The average price target for AstraZeneca is $209.91, which is 20.40% higher than the current price. The consensus rating is "Buy".

Price Target $209.91
Price Target Difference 20.40%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (3Y) 6.75%
EPS Growth Forecast (3Y) 11.21%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AstraZeneca has an Altman Z-Score of 3.6 and a Piotroski F-Score of 6.

Altman Z-Score 3.6
Piotroski F-Score 6